{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:44:34Z","timestamp":1795085074449,"version":"4.10.2"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>Neuroendocrine carcinoma (NEC) is an aggressive malignant tumor that rarely arises from the gallbladder. Here, we investigated the clinicopathologic and immunohistochemical characteristics of 34 NECs of the gallbladder. The patients were predominantly women (68%) with a median age of 63 years (range, 37 to 82\u2009y). NECs frequently occurred in the fundus (44%) as mass-forming lesions (66%). Histologically, 17 tumors were of small cell type, and another 17 were of large cell type. Twenty-three cases (68%) were associated with biliary intraepithelial neoplasia (38%) and intracholecystic papillary neoplasm (29%). The majority of tumors exhibited a diffuse growth pattern (74%), followed by organoid (24%) or scirrhous (2%) growth patterns. Histologic features related to neuroendocrine differentiation, such as nuclear molding (56%), perilobular pseudopalisading (18%), and rosette formation (15%), were identified. Immunohistochemically, cytokeratin 7 and 20 were expressed in 19 (56%) and 8 (24%) cases, respectively. Loss of Rb1 expression and concomitant overexpression of p16 were observed in 25 (74%) cases. No BRAF<jats:sup>V600E<\/jats:sup> mutations were identified in any of the 34 NECs. For survival analysis, the 1-, 3-, and 5-year overall survival rates were 64%, 35%, and 19%, respectively. In a multivariate analysis, the receipt of adjuvant chemoradiation therapy was identified as the only independent prognostic factor associated with the overall survival rate. The 1- and 3-year overall survival rates of patients with NECs were poorer for patients with poorly differentiated adenocarcinoma of the gallbladder (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). The complete resection and application of postoperative adjuvant therapy may influence a better clinical outcome in patients with NEC of the gallbladder.<\/jats:p>","DOI":"10.1097\/pas.0000000000001536","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T23:04:05Z","timestamp":1596323045000},"page":"1308-1321","source":"Crossref","is-referenced-by-count":32,"title":["Neuroendocrine Carcinomas of the Gallbladder"],"prefix":"10.1097","volume":"44","author":[{"given":"Sun Mi","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Pathology, Jeju National University Hospital, Jeju-si"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Ohk","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2011-300831","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)","volume":"61","author":"Ramage","year":"2012","journal-title":"Gut"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/modpathol.2016.220","article-title":"Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas","volume":"30","author":"Jesinghaus","year":"2017","journal-title":"Mod Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000478-200105000-00005","article-title":"Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases","volume":"25","author":"Maitra","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/00365521.2016.1261938","article-title":"Clinicopathological characteristics of biliary neuroendocrine neoplasms: a multicenter study","volume":"52","author":"Lee","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3748\/wjg.v21.i1.269","article-title":"Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder","volume":"21","author":"Yun","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R9-20230922","first-page":"8218","article-title":"Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/modpathol.2016.222","article-title":"SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis","volume":"30","author":"Ishida","year":"2017","journal-title":"Mod Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41379-018-0131-6","article-title":"Identification of high-risk human papillomavirus and Rb\/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma","volume":"32","author":"Shamir","year":"2019","journal-title":"Mod Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.humpath.2015.08.006","article-title":"Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor","volume":"46","author":"Takizawa","year":"2015","journal-title":"Hum Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.21873\/anticanres.13302","article-title":"Frequent and specific involvement of changes of the p16-RB pathway in esophageal neuroendocrine carcinoma","volume":"39","author":"Fujimasa","year":"2019","journal-title":"Anticancer Res"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/modpathol.2016.150","article-title":"In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components","volume":"30","author":"Woischke","year":"2017","journal-title":"Mod Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.18632\/oncotarget.6602","article-title":"Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.6004\/jnccn.2018.7043","article-title":"Targeting BRAF mutations in high-grade neuroendocrine carcinoma of the colon","volume":"16","author":"Burkart","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1245\/s10434-019-07440-6","article-title":"primary gallbladder neuroendocrine tumors: insights into a rare histology using a large national database","volume":"26","author":"Ayabe","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.anndiagpath.2009.08.002","article-title":"Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program","volume":"13","author":"Albores-Saavedra","year":"2009","journal-title":"Ann Diagn Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MCG.0b013e3181d7a6d4","article-title":"Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy","volume":"44","author":"Eltawil","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/PAS.0b013e318242e21c","article-title":"Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers","volume":"36","author":"La Rosa","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"39711","DOI":"10.18632\/oncotarget.14410","article-title":"Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-betaRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker","volume":"8","author":"Yokouchi","year":"2017","journal-title":"Oncotarget"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/PAS.0b013e31826d2639","article-title":"Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases","volume":"37","author":"Huang","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/cncr.21000","article-title":"Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial","volume":"103","author":"Krug","year":"2005","journal-title":"Cancer"},{"key":"R28-20230922","first-page":"25","article-title":"Cytokeratin 7 and 20 expression in gallbladder carcinoma","volume":"62","author":"Kalekou","year":"2011","journal-title":"Pol J Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humpath.2006.06.010","article-title":"A close relationship between intestinal metaplasia and Cdx2 expression in human gallbladders with cholelithiasis","volume":"38","author":"Sakamoto","year":"2007","journal-title":"Hum Pathol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/pin.12029","article-title":"Mixed adenoneuroendocrine carcinoma of the gallbladder with squamous cell carcinomatous and osteosarcomatous differentiation: report of a case","volume":"63","author":"Shintaku","year":"2013","journal-title":"Pathol Int"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/onc.2010.614","article-title":"p16 (Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors","volume":"30","author":"Romagosa","year":"2011","journal-title":"Oncogene"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"111674","DOI":"10.1016\/j.mrfmmm.2019.111674","article-title":"Molecular pathogenesis of gallbladder cancer: an update","volume":"816-818","author":"Mishra","year":"2019","journal-title":"Mutat Res"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00428-004-1046-9","article-title":"Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability","volume":"445","author":"Saetta","year":"2004","journal-title":"Virchows Arch"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/gut.52.5.706","article-title":"Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma","volume":"52","author":"Tannapfel","year":"2003","journal-title":"Gut"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/modpathol.2013.206","article-title":"BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma","volume":"27","author":"Goeppert","year":"2014","journal-title":"Mod Pathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jso.21141","article-title":"Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)","volume":"98","author":"Duffy","year":"2008","journal-title":"J Surg Oncol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/000313481708300721","article-title":"Pathologic and prognostic implications of incidental versus nonincidental gallbladder cancer: a 10-institution study from the United States Extrahepatic Biliary Malignancy Consortium","volume":"83","author":"Ethun","year":"2017","journal-title":"Am Surg"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:59:26Z","timestamp":1695423566000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001536"}},"subtitle":["A Clinicopathologic and Immunohistochemical Analysis of 34 Resected Cases"],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001536","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,29]]}}}